[ RadSafe ] Low-Dose Radiation Numbs Lengthy Post-Shingles Pain
loc at icx.net
Mon Oct 24 14:08:28 CDT 2005
Low-Dose Radiation Numbs Lengthy Post-Shingles Pain
By Ed Susman , MedPage Today Staff Writer
DENVER, Oct. 20 - Low-dose radiation could help relieve long-lasting
post-herpetic neuralgia that often trails a painful herpes zoster
outbreak, Swiss researchers reported.
"We think that radiation is at least as good as antiviral drugs in
preventing post-herpetic neuralgia," said Mohammed Suleiman, M.D., a
radiation oncologist at Hospital of Sion in Switzerland. "This
treatment," he said, "could be an alternative for people who can't take
antiviral medications," such as Zovirax (acyclovir) and Valtrex
Post-herpetic neuralgia endures in about 12% to 15% of people after
shingles and can last for months or years, he noted at a poster
presentation during the American Society for Therapeutic Radiology and
Oncology meeting here.
Since 1975, Dr. Suleiman and colleagues have investigated using low-dose
radiation directly to the rash to relieve acute pain and post-herpetic
neuralgia. In the U.S. more than 800,000 people a year suffer attacks of
shingles, triggered by the varicella zoster virus that caused chickenpox
when they were youngsters.
In a retrospective study, 108 patients were studied in three treatment
periods. From 1975 to 1983, patients received a total radiation dose of
1,250 centigray; from 1983 to 2000, the dose was 1,500 centigray. From
2000 to the present, the dose drifted between 225 and 640 centigray.
Despite the lower dose in the last group, 89% of the patients irradiated
within the first week of the acute attack were pain relief at three
months. By one year, 93% were pain free, Dr. Suleiman said. If the
patients came for treatment between a week and one month, about 88% were
pain free at one year, he said.
Patients were treated three times a week for two weeks. At each visit,
radiation was directed 5 cm to 7 cm into the ganglia with a fraction of
the total radiation dose.
Before radiation, 53 people complained of severe pain, 53 of moderate
pain, and the others of mild or noticeable pain. By six months, all but
11% of patients were pain free. Other reports, Dr. Suleiman said,
indicate that lingering pain remains in about 20% of patients taking
Although the radiation dose is only about one-tenth of that used to
treat cancer, there is a risk of radiation-induced cancer developing
years down the road, Dr. Suleiman noted. "But we have not seen any
secondary cancers, even in patients treated 28 years ago," he said.
Phillip M. Devlin, M.D., director of brachytherapy at Brigham and
Women's Hospital in Boston, a Harvard teaching hospital, said the
researchers "raise a fascinating phenomenon" that should undergo further
However, Dr. Devlin urged caution in using radiation to treat conditions
other than cancer because ionizing radiation itself carries a finite
risk of radiation-induced cancer.
Dr. Suleiman suggested that the radiation may work because it has
anti-inflammatory, antiviral, and antipain effects. He noted that
patients successfully treated with radiation and who achieved pain-free
status did not have a recurrence of pain. He said he would welcome a
controlled clinical trial.
Primary source: American Society for Therapeutic Radiology and Oncology
47th annual meeting
Suleiman, M. Abstract 2333, Radiotherapy for Herpes Zoster in the Acute
Phae: A Retrospective Study with A Long Follow-Up
More information about the RadSafe